Barclays PLC Age X Therapeutics, Inc. Transaction History

Barclays PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$0.93 - $1.54 $38,223 - $63,294	-41,100 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$0.79 - $1.52 $4,811 - $9,258	-6,091 Reduced 12.91%	41,100 $33,000
Q2 2020 Aug 12, 2020	SELL	$0.68 - $1.13 $654 - $1,087	-962 Reduced 2.0%	47,191 $45,000
Q1 2020 May 13, 2020	BUY	$0.78 - $1.95 $20,966 - $52,416	26,880 Added 126.36%	48,153 $44,000
Q4 2019 Feb 10, 2020	BUY	$1.25 - $1.82 $13,361 - $19,453	10,689 Added 100.99%	21,273 $39,000
Q3 2019 Nov 14, 2019	SELL	$1.96 - $3.38 $6,324 - $10,907	-3,227 Reduced 23.37%	10,584 $21,000
Q2 2019 Aug 14, 2019	BUY	$2.58 - $4.92 $22,912 - $43,694	8,881 Added 180.14%	13,811 $50,000
Q1 2019 May 15, 2019	BUY	$3.0 - $4.85 $14,079 - $22,761	4,693 Added 1980.17%	4,930 $19,000
Q4 2018 Feb 14, 2019	BUY	$2.49 - $5.5 $590 - $1,303	237 New	237 $0

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.